Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
about
Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disordersHuman cyclophilin 40 unravels neurotoxic amyloids.Emerging roles of extracellular vesicles in neurodegenerative disorders: focus on HIV-associated neurological complications.Neuropathology of α-synuclein propagation and braak hypothesis.Review: Parkinson's disease: from synaptic loss to connectome dysfunction.α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.Treatments and compositions targeting α-synuclein: a patent review (2010-2016).Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies.Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.Spinal cord injury and Parkinson's disease: a population-based, propensity score-matched, longitudinal follow-up study.Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD.Upregulation of autophagy-related gene 5 protects dopaminergic neurons in a zebrafish model of Parkinson's disease.How close are we to revealing the etiology of Parkinson's disease?Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration.Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers.Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease
P2860
Q21146612-E069132F-D4EA-4154-9F7D-5941A6D8EE9FQ33842022-19D9ED40-E92F-4C27-A193-6C39B10A1084Q37603356-A6CF81D8-892B-4001-AB82-85AE23EB0FF2Q38580816-B9C7676B-342E-47B6-8D34-B62E22D87F4EQ38650395-40822194-46B1-48CF-9274-8EA169EB5FD3Q38912683-9C6E2B90-2722-4DDA-AC00-B15A606549AAQ39007523-EDD46EE5-ACDA-4E4F-8E18-953844B63741Q39109344-A3B76ADF-9FDF-400A-9EB4-8D82CF332CABQ39151939-5094206D-48D8-4D9D-BDEA-68D0858666FFQ39264615-59526B15-310C-4F78-A038-E5182562FF17Q40728161-A8560700-EF48-403F-AE5E-F3030395261BQ41570439-0E76BA53-4EBD-4884-AD8C-9E503EBF8F85Q41996328-425A2C92-B49C-4140-8D5A-43FB425BA200Q53371751-6C6FE124-94F6-460B-9B07-CD6903408734Q55152170-3425F8A0-4CCC-4AF0-9D2A-C3BD33AB3624Q55443026-AA28CEDF-1F79-48FC-A6F2-721893FEDD09Q58781782-DEA5C06F-7A7D-4D59-AE84-DEE9236E7CDF
P2860
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@ast
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@en
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@nl
type
label
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@ast
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@en
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@nl
prefLabel
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@ast
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@en
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@nl
P2093
P2860
P356
P1476
Features of alpha-synuclein th ...... ibility of Parkinson's disease
@en
P2093
Carla Pacheco
Christian Peters
Luis G Aguayo
Scarlet Gallegos
P2860
P356
10.3389/FNINS.2015.00059
P407
P50
P577
2015-03-09T00:00:00Z